-
1
-
-
0028801975
-
A prospective evaluation of plasma prostate-specific antigen for detection of prostatic cancer
-
Gann PH, Hennekens CH, Stampfer MJ. A prospective evaluation of plasma prostate-specific antigen for detection of prostatic cancer. JAMA 1995;273:289-94.
-
(1995)
JAMA
, vol.273
, pp. 289-294
-
-
Gann, P.H.1
Hennekens, C.H.2
Stampfer, M.J.3
-
2
-
-
0030913316
-
Prostate cancer detection in men with serum PSA concentrations of 2.6 to 4.0 ng/mL and benign prostate examination. Enhancement of specificity with free PSA measurements
-
Catalona WJ, Smith DS, Ornstein DK. Prostate cancer detection in men with serum PSA concentrations of 2.6 to 4.0 ng/mL and benign prostate examination. Enhancement of specificity with free PSA measurements. JAMA 1997;277:1452-5.
-
(1997)
JAMA
, vol.277
, pp. 1452-1455
-
-
Catalona, W.J.1
Smith, D.S.2
Ornstein, D.K.3
-
3
-
-
0038497523
-
Effect of verification bias on screening for prostate cancer by measurement of prostate-specific antigen
-
Punglia RS, D'Amico AV, Catalona WJ, Roehl KA, Kuntz KM. Effect of verification bias on screening for prostate cancer by measurement of prostate-specific antigen. N Engl J Med 2003;349:335-42.
-
(2003)
N Engl J Med
, vol.349
, pp. 335-342
-
-
Punglia, R.S.1
D'Amico, A.V.2
Catalona, W.J.3
Roehl, K.A.4
Kuntz, K.M.5
-
4
-
-
0028800933
-
Evaluation of percentage of free serum prostate-specific antigen to improve specificity of prostate cancer screening
-
Catalona WJ, Smith DS, Wolfert RL, et al. Evaluation of percentage of free serum prostate-specific antigen to improve specificity of prostate cancer screening. JAMA 1995;274:1214-20.
-
(1995)
JAMA
, vol.274
, pp. 1214-1220
-
-
Catalona, W.J.1
Smith, D.S.2
Wolfert, R.L.3
-
5
-
-
0030447621
-
Analysis of percent free prostate-specific antigen (PSA) for prostate cancer detection: Influence of total PSA, prostate volume, and age
-
Partin AW, Catalona WJ, Southwick PC, Subong EN, Gasior GH, Chan DW. Analysis of percent free prostate-specific antigen (PSA) for prostate cancer detection: influence of total PSA, prostate volume, and age. Urology 1996;48:55-61.
-
(1996)
Urology
, vol.48
, pp. 55-61
-
-
Partin, A.W.1
Catalona, W.J.2
Southwick, P.C.3
Subong, E.N.4
Gasior, G.H.5
Chan, D.W.6
-
6
-
-
0036093267
-
Strategies combining total and percent free prostate specific antigen for detecting prostate cancer: A prospective evaluation
-
Gann PH, Ma J, Stampfer MJ. Strategies combining total and percent free prostate specific antigen for detecting prostate cancer: a prospective evaluation. J Urol 2002;167:2427-34.
-
(2002)
J Urol
, vol.167
, pp. 2427-2434
-
-
Gann, P.H.1
Ma, J.2
Stampfer, M.J.3
-
7
-
-
0034048942
-
Complexed prostate specific antigen provides significant enhancement of specificity compared with total prostate specific antigen for detecting prostate cancer
-
Brawer MK, Cheli CD, Neaman IE, et al. Complexed prostate specific antigen provides significant enhancement of specificity compared with total prostate specific antigen for detecting prostate cancer. J Urol 2000;163:1476-80.
-
(2000)
J Urol
, vol.163
, pp. 1476-1480
-
-
Brawer, M.K.1
Cheli, C.D.2
Neaman, I.E.3
-
8
-
-
0033992457
-
Examination of the 3 molecular forms of serum prostate specific antigen for distinguishing negative from positive biopsy: Relationship to transition zone volume
-
Stamey TA, Yemoto CE. Examination of the 3 molecular forms of serum prostate specific antigen for distinguishing negative from positive biopsy: relationship to transition zone volume. J Urol 2000;163:119-26.
-
(2000)
J Urol
, vol.163
, pp. 119-126
-
-
Stamey, T.A.1
Yemoto, C.E.2
-
11
-
-
2942658010
-
Combining biomarkers to detect disease with application to prostate cancer
-
Etzioni R, Kooperberg C, Pepe MS, Smith R, Gann PH. Combining biomarkers to detect disease with application to prostate cancer. Biostatistics 2003;4:523-38.
-
(2003)
Biostatistics
, vol.4
, pp. 523-538
-
-
Etzioni, R.1
Kooperberg, C.2
Pepe, M.S.3
Smith, R.4
Gann, P.H.5
-
12
-
-
0033638552
-
Identifying combinations of cancer markers for further study as triggers of early intervention
-
Baker SG. Identifying combinations of cancer markers for further study as triggers of early intervention. Biometrics 2000;56:1082-7.
-
(2000)
Biometrics
, vol.56
, pp. 1082-1087
-
-
Baker, S.G.1
-
14
-
-
0041488899
-
Semiparametric regression for the area under the receiver operating characteristic curve
-
Dodd LE, Pepe MS. Semiparametric regression for the area under the receiver operating characteristic curve. J Am Stat Assoc 2003;98:409-17.
-
(2003)
J Am Stat Assoc
, vol.98
, pp. 409-417
-
-
Dodd, L.E.1
Pepe, M.S.2
-
15
-
-
0001529952
-
Prospective evaluation of percent free-PSA and complexed-PSA for early detection of prostate cancer
-
Partin AW, Brawer MK, Subong EN, et al. Prospective evaluation of percent free-PSA and complexed-PSA for early detection of prostate cancer. Prostate Cancer Prostatic Dis 1998;1:197-203.
-
(1998)
Prostate Cancer Prostatic Dis
, vol.1
, pp. 197-203
-
-
Partin, A.W.1
Brawer, M.K.2
Subong, E.N.3
-
16
-
-
0036229722
-
Comparative analysis of complexed prostate specific antigen, free prostate specific antigen and their ratio in detecting prostate cancer
-
discussion 23-4
-
Okihara K, Cheli CD, Partin AW, et al. Comparative analysis of complexed prostate specific antigen, free prostate specific antigen and their ratio in detecting prostate cancer. J Urol 2002;167:2017-23; discussion 23-4.
-
(2002)
J Urol
, vol.167
, pp. 2017-2023
-
-
Okihara, K.1
Cheli, C.D.2
Partin, A.W.3
-
17
-
-
0032550630
-
Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease: A prospective multicenter clinical trial
-
Catalona WJ, Partin AW, Slawin KM, et al. Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease: a prospective multicenter clinical trial. JAMA 1998;279:1542-7.
-
(1998)
JAMA
, vol.279
, pp. 1542-1547
-
-
Catalona, W.J.1
Partin, A.W.2
Slawin, K.M.3
-
18
-
-
17144466104
-
Usefulness of the ratio free/total prostate-specific antigen in addition to total PSA levels in prostate cancer screening
-
Reissigl A, Klocker H, Pointner J, et al. Usefulness of the ratio free/total prostate-specific antigen in addition to total PSA levels in prostate cancer screening. Urology 1996;48:62-6.
-
(1996)
Urology
, vol.48
, pp. 62-66
-
-
Reissigl, A.1
Klocker, H.2
Pointner, J.3
|